Prostate Cancer Canada

What We're Funding

For more information visit
www.movember.com

In The News

Media Advisory - Prostate Cancer Canada celebrates local Vancouver Hero
Vancouver, British Colombia, April 16 –– Prostate Cancer Canada will honour the late Jack Poole, former VANOC Board Chair and local businessman, with the Local Hero Award. Jack was a generous benefactor to the Vancouver General Hospital and UBC Hospital Foundation with gifts totalling $3 Million for “Jack the Robot”, a da Vinci S HD surgical system, and a $1 Million gift towards the Robert H. N. Ho Research Centre. His lead donation attracted a further $3.5 million in donations including $1.5 million from Jimmy Pattison. Together these donations enabled VGH to become the fourth Canadian hospital to employ robotic technology in surgery.

Media Advisory- Prostate Cancer Canada celebrates local Calgary Hero
Calgary, AB, April 10 –– Local Hero Dr. Jay Lee will be honoured on April 11th at the annual Wake Up Call Breakfast, hosted by Prostate Cancer Canada, in partnership with the Prostate Cancer Centre. Dr. Lee is being recognized for his extraordinary contribution to the fight against prostate cancer.

Click For Information Archive

Collaboration

The prostate cancer field is complex, and we need large and diverse teams to tackle the intricate issues from many perspectives. With that in mind, we are committed to supporting collaborative research and survivorship efforts. Examples of such projects include:

CPC-GENE

CPC-GENE is one of Canada’s contributions to the International Cancer Genome Consortium and links with other related prostate cancer activities around the world.

The research aims to identify genetic mutations in the genomes of prostate cancers, information that could be used to better detect tumours, determine tumour aggressiveness and identify the best treatment needed to personalize prostate cancer medicine for individual patients.

This is just one example of large-scale research programs that will make a difference in the field of prostate cancer research.

[Read more]

PC-STAR

This project, funded by Safeway, is conducted by researchers at the Prostate Cancer Centre in Vancouver. The study aims to develop new treatments for prostate cancer when the tumour has spread and become hormone independent. Possible approaches include using computer technology for drug design, screening with a series of small molecules to find any that could potentially be effective drugs, and testing biological agents.

BRCA I/II

This national study looks at men who carry BRCA 1 and BRCA 2 genetic mutations, comparing those who have a family history of prostate cancer with patients who do not. The hypothesis is that patterns in the expression of proteins between these two groups could reveal important biomarkers in the diagnosis, prognosis and treatment of prostate cancer. The study is being led by a group of researchers in Toronto but involves collaborations with other researchers across Canada.

"Prostate cancer research is flourishing in Canada with important new work and discoveries taking place each year, which will no doubt help men everywhere with prostate cancer.” Dr. Robert Bristow, Pilot Grant recipient and head of BRCA1/2

Movember Team Grants

The new Movember Team Grants program provides funding to collaborative and innovative research teams in the field of prostate cancer. The program will facilitate collaboration between not only researchers but also institutions, providing an increasingly united approach to prostate cancer research. The opportunity unites researchers with the best minds in their shared fields from coast to coast.